title: Introduction and commentary: Biosimilars-clinical trial and safety considerations.
authors.affiliation: Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University Vienna, Wien, Austria. Electronic address: reinisw@mcmaster.ca.
authors.forename: Walter
authors.initials: W
authors.lastname: Reinisch
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000592:standards* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D061214:Patient Safety
chemical_list: D059451:Biosimilar Pharmaceuticals